Piperlongumine inhibits zika virus replication In vitro and promotes up-regulation of HO-1 expression, suggesting an implication of oxidative stress
Effect of siponimod on magnetic resonance imaging measures of neurodegeneration and myelination in secondary progressive multiple sclerosis: Gray matter atrophy and magnetization transfer ratio analyses from the EXPAND phase 3 trial
older adults most vulnerable Weight regain: average 9.69 kg after stopping, mostly fat Nutritional deficiencies: protein, B12, and micronutrients What this means clinically: Screen for eating disorder history before prescribing Monitor for anhedonia, mood changes, and restrictive eating patterns Order baseline and repeat ferritin, B12, and vitamin D Prescribe resistance training and protein targets alongside the medication Monitor body composition, not just weight Have the length of treatment and cessation conversation at initiation We are iterating in real time on a drug class taken by tens of millions of people
Most patients travel 2030 minutes for their initial consultation and lab draw, then manage follow-up protocols from home
Purification of the body Alongside its antioxidant power, glutathione protects the body in other ways
What this means in practice: compounded GLP-1 medications may carry risks that differ from those of FDA-approved branded products